Humacyte V007 Phase 3 dialysis access trial results published
Humacyte (HUMA) announces that its V007 Phase 3 hemodialysis access trial results have been published in Lancet Digital Health.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results.
Humacyte (HUMA) announces that its V007 Phase 3 hemodialysis access trial results have been published in Lancet Digital Health.